Beijing Kawin Technology Share-Holding Co Ltd Class A 688687
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥23.65
- Day Range
- ¥25.21–28.38
- 52-Week Range
- ¥18.50–37.63
- Bid/Ask
- ¥28.20 / ¥28.21
- Market Cap
- ¥4.82 Bil
- Volume/Avg
- 10.3 Mil / 2.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 31.49
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- 1.06%
- Dividend Yield (Forward)
- 1.06%
- Total Yield
- 1.06%
Company Profile
Beijing Kawin Technology Share-Holding Co Ltd is a biotechnology company. It offers healthcare solutions for liver disease. The company's products include Pirfenidone Tablets, Peginterferon Alfacon-2 Injection, and Compound glycyrrhizin capsules.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 584
- Website
- http://www.kawin.com.cn
Comparables
Valuation
|
Metric
|
688687
|
300142
|
300723
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.49 | 65.42 | 52.75 |
Price/Book Value | 2.30 | 2.07 | 2.84 |
Price/Sales | 2.76 | 5.81 | 3.16 |
Price/Cash Flow | 22.55 | 18.10 | 23.22 |
Price/Earnings
688687
300142
300723
Financial Strength
|
Metric
|
688687
|
300142
|
300723
|
|---|---|---|---|
Quick Ratio | 3.15 | 2.51 | 0.48 |
Current Ratio | 3.48 | 2.94 | 0.92 |
Interest Coverage | 144.82 | 24.73 | 2.55 |
Quick Ratio
688687
300142
300723
Profitability
|
Metric
|
688687
|
300142
|
300723
|
|---|---|---|---|
Return on Assets (Normalized) | 5.34% | 1.93% | 0.20% |
Return on Equity (Normalized) | 7.26% | 3.16% | 0.35% |
Return on Invested Capital (Normalized) | 5.95% | 2.01% | 0.91% |
Return on Assets
688687
300142
300723
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Rdbjkhgdq | Yfwk | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Nszsvlsh | Jgrgwk | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Jvfzdvcg | Spbxbb | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Kzpfkltr | Wcwrqfh | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Cbdfszp | Bjpg | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Zdczlrswc | Qmhm | $28.1 Bil | |||
| Moderna Inc
MRNA
| Mnfdbldk | Wyvx | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Pvlytltt | Ccs | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Nyvrncj | Krxltg | $13.4 Bil | |||
| Incyte Corp
INCY
| Trdpqftqn | Jnpng | $12.7 Bil |
United States